Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin-Reference-Cited by-同舟云学术

Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin

Published:2001-11 Issue:5 Volume:134 Page:1104-1112
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Jurasz Paul,Stewart Michael W,Radomski Anna,Khadour Fadi,Duszyk Marek,Radomski Marek W

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704343/fullpdf

Reference49 articles.

1. Immunoquantitation of factor VIII-related antigen (von Willebrand factor antigen) in prostate cancer;ABLIN;Cancer Letts,1988

2. Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition of studies with apyrase, hirudin, and phospholipase;BASTIDA;Cancer Res.,1982

3. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies;BERGMEIER;Blood,2000

4. Platelet-vessel wall interaction: from the bedside to molecules;CAEN;Thromb. Haemostas.,1995

5. Mechanisms of enhanced intrahepatic metastasis in surfactant treated hampsters: an electron microscopy study;COTMORE;Int. J. Cancer,1973

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Nitric Oxide in Megakaryocyte Function;International Journal of Molecular Sciences;2023-05-02

2. In Search of the Holy Grail: Stem Cell Therapy as a Novel Treatment of Heart Failure with Preserved Ejection Fraction;International Journal of Molecular Sciences;2023-03-03

3. Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+‐activated potassium channels;Journal of Thrombosis and Haemostasis;2022-11

4. Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy;Frontiers in Oncology;2022-06-23

5. Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma;Frontiers in Oncology;2022-06-08